Itau Unibanco Holding S.A. Allogene Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$2.23 - $4.38 $14,171 - $27,834
6,355 New
6,355 $14,000
Q4 2023

Feb 14, 2024
BUY
$2.28 - $3.5 $10,175 - $15,620
4,463 Added 94.98%
9,162 $29,000
Q3 2023

Nov 14, 2023
BUY
$3.17 - $5.96 $3,661 - $6,883
1,155 Added 32.59%
4,699 $14,000
Q2 2023

Aug 14, 2023
BUY
$4.53 - $6.74 $16,054 - $23,886
3,544 New
3,544 $17,000

Others Institutions Holding ALLO

# of Institutions
165
Shares Held
134M
Call Options Held
59.4K
Put Options Held
113K
View Full List

About Allogene Therapeutics, Inc.

ALLO Quotes by TradingView
  • Ticker ALLO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 143,807,008
  • Market Cap $279M
  • Description
  • Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...
More about ALLO
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email